Holen Sie sich die Stockscreener-App
109.86
2.53%
-2.85
Vorhandelsmarkt:
108.05
-1.81
-1.65%
Schlusskurs vom Vortag:
$112.71
Offen:
$110.98
24-Stunden-Volumen:
15.21M
Relative Volume:
1.57
Marktkapitalisierung:
$N/A
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.55%
1M Leistung:
+6.04%
6M Leistung:
+31.57%
1J Leistung:
+10.67%
1-Tages-Spanne:
$107.89
$111.93
1-Wochen-Bereich:
$107.89
$113.21
52-Wochen-Spanne:
$66.66
$113.21
State Street Spdr S P Biotech Etf Stock (XBI) Company Profile
Firmenname
State Street Spdr S P Biotech Etf
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie XBI mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
XBI
State Street Spdr S P Biotech Etf
|
109.86 | 0 | 0 | 0 | 0 | 0.00 |
|
VTI
Vanguard Total Stock Market Etf
|
335.80 | 417.53B | 0 | 0 | 0 | 0.00 |
|
SPY
Spdr S P 500 Etf Trust
|
683.34 | 372.57B | 0 | 0 | 0 | 0.00 |
|
IVV
Ishares Core S P 500 Etf
|
686.69 | 253.41B | 0 | 0 | 0 | 0.00 |
|
VB
Vanguard Small Cap Etf
|
254.42 | 160.59B | 0 | 0 | 0 | 0.00 |
|
QQQ
Invesco Qqq Trust Series 1
|
632.08 | 124.43B | 0 | 0 | 0 | 0.00 |
State Street Spdr S P Biotech Etf Aktie (XBI) Neueste Nachrichten
SPDR S&P Biotech ETF Options Spot-On: On November 3rd, 78,510 Contracts Were Traded, With 811.5K Open Interest - 富途牛牛
Biotech ETFs Come Alive As Illumina Soars 23% — Is The Genomics Winter Finally Over? - Benzinga
It's a high-risk trade, but this biotech down 80% this year could be a buy - CNBC
Top 6 ETFs To Watch As Wall Street's Strongest Six Months Begin - Benzinga
Biotech ETFs Hovering Around a 52-Week: Here's Why - TradingView
StockWatch: Top 3 Biotech ETFs Finally Bounce Back with the Market - Genetic Engineering and Biotechnology News
Have Biotech Stocks Returned To Health After Years Of Sickness? - Investor's Business Daily
Analyst Says He’s Buying This Biotech ETF, Predicts ‘Multi-Year’ Breakout - Insider Monkey
Guarantor: JPMorgan Chase & Co. - StreetInsider
Biotech Is Finally Rallying. Why Mizuho’s Jared Holz Is Optimistic This Time. - Barron's
XBI, CRSP, INSM, IONS: Large Inflows Detected at ETF - Nasdaq
The Technical Signals Behind (XBI) That Institutions Follow - news.stocktradersdaily.com
SciSparc Expands Biotech Ambitions, Buys Stake In Miza III Ventures - Sahm
(XBI) and the Role of Price-Sensitive Allocations - news.stocktradersdaily.com
(XBI) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Discipline and Rules-Based Execution in XBI Response - news.stocktradersdaily.com
String of acquisitions fuels biotech optimism - Sherwood News
Should You Invest in the SPDR S&P Biotech ETF (XBI)? - Yahoo Finance
Truist Financial Corp Sells 5,213 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Vontobel Holding Ltd. Sells 7,846 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Price-Driven Insight from (XBI) for Rule-Based Strategy - news.stocktradersdaily.com
Behavioral Patterns of XBI and Institutional Flows - news.stocktradersdaily.com
Technical Reactions to XBI Trends in Macro Strategies - news.stocktradersdaily.com
Understanding Momentum Shifts in (XBI) - news.stocktradersdaily.com
Understanding the Setup: (XBI) and Scalable Risk - news.stocktradersdaily.com
(XBI) Movement as an Input in Quant Signal Sets - news.stocktradersdaily.com
How Spdr Biotech Etf (XBI) Affects Rotational Strategy Timing - news.stocktradersdaily.com
(XBI) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Trading the Move, Not the Narrative: (XBI) Edition - news.stocktradersdaily.com
Avoiding Lag: Real-Time Signals in (XBI) Movement - news.stocktradersdaily.com
Ramirez Asset Management Inc. Sells 200 Shares of SPDR S&P Biotech ETF $XBI - Defense World
Prime Capital Investment Advisors LLC Grows Stock Holdings in SPDR S&P Biotech ETF $XBI - Defense World
Why (XBI) Price Action Is Critical for Tactical Trading - news.stocktradersdaily.com
Responsive Playbooks and the XBI Inflection - news.stocktradersdaily.com
SPDR S&P Biotech ETF declares quarterly distribution of $0.0267 - MSN
VanEck Biotech ETF (BBH): How to Buy - The Motley Fool
Janney Montgomery Scott LLC Decreases Stock Holdings in SPDR S&P Biotech ETF $XBI - Defense World
4 Biotech Stocks Seeing Explosive Momentum GainsAldeyra Therapeutics (NASDAQ:ALDX) - Benzinga
How Trump's Shutdown Standoff Could Hand Health-Care ETFs A Lifeline - Benzinga
SciSparc And AutoMax Call Off Merger - Sahm
Biotech Stocks Are Up. The Sector Is Looking Better Than It Has in Years. - Barron's
Precision Trading with Spdr Biotech Etf (XBI) Risk Zones - news.stocktradersdaily.com
The Best Biotech ETFs to Buy - inkl
Finanzdaten der State Street Spdr S P Biotech Etf-Aktie (XBI)
Es liegen keine Finanzdaten für State Street Spdr S P Biotech Etf (XBI) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.47%
0.60%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):